Clinical Trials Logo

Citation(s)

Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 in Treating Patients With Refractory Esophageal Cancer

Details for clinical trial NCT00681330